Novavax Price Target Raised to $290 from $132 at H.C. Wainwright

H.C. Wainwright analyst Vernon Bernardino raised the firm's price target on Novavax to $290 from $132 and keeps a Buy rating on the shares.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.